Company Overview of Acton Pharmaceuticals, Inc.
Acton Pharmaceuticals, Inc., a respiratory specialty pharmaceutical company, acquires, develops, and commercializes products to treat allergic, pulmonary, and other respiratory related diseases. Its AEROSPAN Inhalation Aerosol is an orally inhaled corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 6 years of age and older. The company was founded in 2008 and is headquartered in Marlborough, Massachusetts. As of October 21, 2013, Acton Pharmaceuticals, Inc. operates as a subsidiary of Meda AB.
225 Cedar Hill Street
Marlborough, MA 01752
Founded in 2008
Key Executives for Acton Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Santaris Pharma A/S Corp||United States|
|Tensha Therapeutics, Inc.||United States|
|Taisho Pharmaceutical R&D Inc.||United States|
|Jaguar Animal Health, Inc.||United States|
|Aerovance, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Acton Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.